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Abstract 
 
Background: Hypertension is one of the most common chronic diseases worldwide and 
is estimated to contribute 9% of all deaths in South Africa, where it is also the 
commonest condition seen in ambulatory primary care. Despite advances in treatment 
of this disease and clear guidelines, quality of care is still lacking.  
Aim: To improve the quality of hypertension care by means of a Quality Improvement 
Cycle. 
Setting: Cloetesville Community Day Centre, Stellenbosch, Western Cape 
 
Methods: Two hundred folders were randomly selected and audited. Following this, 
interventions to improve clinical practice included training of nursing staff on taking 
blood pressure measurements accurately, teaching sessions on the latest evidence 
based hypertension guidelines and promoting standardised quality of care. A re audit 
was done one year later and the results compared. 
Results: Fifty nine per cent were women with a mean age of 58 years. In both audits all 
of the structural target standards were met. During the re-audit only 3/12 process 
target standards were met, but there was a significant improvement (p<0.05) in 9/12 
criteria. Blood pressure control was achieved in 61% of patients showing a slight 
improvement from the baseline audit of 57%. 
 
Conclusion: The quality improvement cycle demonstrated significant improvements in 
the process and outcome of care following relatively simple interventions and changes 
to clinical practice. It is recommended that the quality improvement process should 
continue with new interventions, be expanded to other health centres in this sub district 
and beyond and to other chronic diseases.   
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Introduction 
Hypertension is one of the most common chronic diseases worldwide affecting about 
one billion people and is the commonest cardiovascular disease.1 Hypertension was the 
foremost cause of death worldwide in 2008 and responsible for 14% of global mortality 
or about 7.5 million deaths.2 The importance of hypertension was recognised by the 
World Health Organization (WHO) when they dedicated the 2013 World Health Day to 
hypertension.1   
The number of deaths attributable to hypertension is higher in low- (2.0 million) and 
middle-income countries (4.2 million), when compared to high-income countries (1.4 
million), highlighting the higher burden in poorer regions. In Sub-Saharan Africa 25% of 
under-60 year mortality is attributed to hypertension, compared to only 7% in high-
income countries.2 Hypertension therefore is a major burden of disease in developed as 
well as developing countries like South Africa (SA), which is already burdened by 
tuberculosis and HIV.3, 4, 5, 6 
In South Africa hypertension is the leading reason to attend primary care and the most 
common diagnosis (as HIV and TB are treated in separate vertical programmes).7 In 
South Africa hypertension is also one of the leading causes of death, causing 9% of all 
deaths.8 An estimated 53 men and 78 women die in South Africa each day from the 
impact of hypertension.2 The Medical Research Council (MRC) estimates that more than 
6.3 million South Africans have blood pressure higher than 140/90 mm Hg and more 
than 3.2 million have blood pressure higher than 160/95 mm Hg, a level that is 
unacceptably high.9 
In the Western Cape chronic diseases are a growing problem and currently cause the 
largest proportion of all deaths.10 Hypertension is the sixth leading cause of premature 
death in the Western Cape and one of the top ten causes of death in Stellenbosch, the 
setting for this study.10 
It is estimated that the majority of cases of hypertension go undiagnosed and therefore 
untreated.3 Furthermore those patients treated for hypertension are often poorly 
controlled. This leads to a high complication rate with serious complications such as 
coronary artery disease (CAD), cardiac failure, chronic renal failure (CRF), cerebro-
vascular disease (CVAs), peripheral vascular disease and retinopathy.7 Studies have 
shown that high blood pressure (BP) accounts for 66% of CVAs and almost 50% of 
CAD.8, 11 
Hypertension is also ranked as the third highest cause of Disability-Adjusted Life Years 
globally.12, 13Such impairment leads to a decrease in productivity and income, which has 
implications for maintaining poverty and inequality. It also has major financial 
implications in a country like South Africa where it is estimated that hypertension 
constituted 7.5% of the total health expenditure in recent years, which amounts to over 
5 billion rand annually.14, 15, 16, 17  
Therefore the diagnosis and effective management of blood pressure is crucial. Along 
with pharmacological interventions, and irrespective of the level of hypertension, BP 
reduction by non-pharmacological means is equally important and always preferable. 
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Interventions that have proven effective include weight loss, modification of eating 
habits with increased fruit and vegetable and decreased saturated and total fat intake, 
reductions in salt and alcohol consumption, and increases in physical activity. 12, 18 
Non pharmacological measures as well as medication can contribute to systolic blood 
pressure reduction. For example the Dietary Approaches to Stop Hypertension (DASH) 
low sodium diet reduces the SBP by 2-8 mmHg, and weight reduction of 10Kg can 
contribute to a reduction of 5-20mmHg.19 In South Africa obesity is associated with 
poorer control and interventions targeting diet and physical activity should be given the 
highest possible priority.20 
 
Furthermore there is evidence that treatment to specific targets can reduce morbidity 
and mortality.15, 19Antihypertensive therapy when optimally prescribed is amongst the 
most effective means for lowering BP and is associated with a marked reduction in CVD 
morbidity and mortality related to stroke, heart attack, heart failure, and chronic kidney 
disease.21 In the short term, the most effective strategy to reduce the burden of 
hypertension is through use of simple medication.22A reduction of 5-6 mmHg in 
diastolic pressure has shown to reduce the incidence of stroke by 40%, coronary events 
by 15% and heart failure by 50%.15 
In South Africa, however, only 21% of men and 36% of women with hypertension are 
taking medication to reduce their blood pressure, while only 10% of men and 18% of 
women have their blood pressure levels reduced to the target that will minimise the 
risk to their hearts, brain and kidneys.9  
Although there is a problem with under recognition and under treatment of 
hypertension in South Africa, there may also be a risk of inappropriate diagnosis (based 
on single poorly standardised readings) and over treatment of mild hypertension. A 
recent meta-analysis looking at the pharmacotherapy for mild hypertension (SBP 140-
159mmHg or DBP 90-99mmHg) found that pharmacologic treatment of mild 
hypertension for up to five years does not reduce coronary events, stroke, or mortality 
compared with placebo.23  
It may therefore be better to focus on those with moderate-severe hypertension and a 
high overall cardiovascular disease risk score. Hypertension should not be seen in 
isolation from a person’s overall CVD risk and tools have recently been developed in 
South Africa to quantify the 5-year risk of a cardiovascular event (based on a person’s 
age, gender, blood pressure, smoking status, BMI and diagnosis of diabetes). In this 
approach hypertension is seen as a risk factor for cardiovascular disease, rather than a 
disease in itself. The early detection, treatment and control of hypertension are then 
central to the management of cardiovascular disease risk.21Importantly also is that a 
systemic approach to total CVD risk estimation seems to result in better risk factor and 
in this case BP control.24 
Other aspects to keep in mind in CVD risk stratification and management include low 
dose aspirin (75 mg/day), which is recommended for secondary prevention of 
ischaemic heart disease and for primary prevention, in people over the age of 50 who 
have a 10 year risk of cardiovascular disease of ≥ 20%.25 Statins are recommended for 
all people with high blood pressure complicated by cardiovascular disease, irrespective 
of baseline concentrations total cholesterol or low density lipoprotein (LDL) 
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cholesterol. Statins are also recommended for primary prevention in people with high 
blood pressure who have a 10 year risk of cardiovascular disease of ≥ 20%.25 
With a range of different treatment modalities available it is however important to note 
that there is a wide gap between the potential to control BP and the actual achievement 
of control. Barriers to optimal hypertension management include the healthcare service, 
the healthcare provider and the patient, indicating that a multifactorial approach is 
required to improve the outcome.18 It is clear from several systemic reviews that the 
answer to improving patient care for chronic diseases is in person centred management 
and not necessarily new therapies.26  Hypertensive care may also be complicated by 
multi-morbidity and at least 40% of patients have another disease, typically diabetes, 
osteoarthritis, asthma or chronic obstructive pulmonary disease.27 Such complexity is 
challenging for primary care nurses and also suggests a need to attend to more 
individualised goals in chronic care.27, 28 
Hypertension care is notoriously suboptimal as seen in the local Integrated Audit of 
Chronic Disease Management (IACDM), although slowly and gradually improving over 
time. Other local audits conducted over the past few years in the Cape Town area show 
that chronic disease care remains suboptimal.29, 30 
Studies have shown that quality improvement cycles (QIC) are an essential part of 
improving and maintaining an acceptable standard of care for chronic diseases.31, 32, 33   
This has also been shown in audit of chronic diseases in our local setting.34 In addition a 
meta-analysis of QICs for hypertension has shown a significant effect on hypertension 
control.35 
From my time working one day a week in the community day centre (CDC) it is clear 
that there are major short comings with regards to chronic care although this has never 
really been assessed. The guidelines are not followed and most patients seem to have 
uncontrolled blood pressure. There is also a need for better organisational systems in 
the facility and better communication between the CDC and the district hospital. 
Although audits on hypertension care in the Western Cape have been done before, to 
the best knowledge of the researcher there has not been a study or QIC in this sub 
district. It is interesting to note that there are significant differences in quality of care 
for chronic diseases in health centres within the same province.30  In 2009, the 
Provincial Government of the Western Cape (PGWC) developed the Adult Chronic 
Disease Management Policy which proposes regular clinical audits (using a specifically 
developed tool) to assess the quality of care delivered and the attainment of treatment 
goals.36 The IACDM tool from the Department of Health in the Western Cape only 
examines 10 patient files per facility and does not always complete the cycle by 
reflecting on and changing clinical practice. Therefore this study will be more valid at 
the level of the facility and should have an impact on the local community and 
healthcare. 
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Aim 
To improve the quality of hypertension care at Cloetesville Community Day Centre by 
means of a Quality Improvement Cycle. 
 
Objectives 
 To create target standards for hypertension care specific for Cloetesville 
Community Day Centre  
 To perform a baseline audit of the quality of hypertension care  
 To plan and implement change to improve the quality of hypertension care 
 To re-evaluate the quality of care after the implemented changes. 
 To make recommendations on hypertension care for the sub-district. 
Methods 
Study design  
The WONCA Working Party on Quality in Family Medicine defines quality as ‘’the best 
health outcomes that are possible, given available resources, and that are consistent 
with patient values and preferences’’.3 7Medical Audit, also known as Clinical Audit and 
Quality Improvement (QI) Cycle, is the centre of the process of Continuous Quality 
Improvement (CQI). Quality of Care (QOC) is one of the pillars of Clinical Governance, 
the concept that refers to the accountability of a health care system for ensuring the 
correct standard of care provided to its patients.38 
The following definition of clinical (medical) audit is endorsed by the National Institute 
of Clinical Excellence (NICE), United Kingdom: “Clinical audit is a quality improvement 
process that seeks to improve patient care and outcomes through systematic review of 
care against explicit criteria and the implementation of change. Aspects of the structure, 
processes, and outcomes of care are selected and systematically evaluated against 
explicit criteria. Where indicated, changes are implemented at an individual, team, or 
service level and further monitoring is used to confirm improvement in healthcare 
delivery.”39 
The foreword of Principles for Best Practice in Clinical Audit (published by National 
Institute of Clinical Excellence, UK), provides an eloquent summary of the pivotal role of 
the medical audit:  
“Clinical audit is at the heart of clinical governance. 
a) It provides the mechanisms for reviewing the quality of everyday care 
provided to patients with common conditions like hypertension, asthma or 
diabetes. 
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b) It builds on a long history of doctors, nurses and other healthcare 
professionals reviewing case notes and seeking ways to serve their patients 
better. 
c) It addresses quality issues systematically and explicitly, providing reliable 
information.39 
d) It can confirm the quality of clinical services and highlight the need for 
improvement.” 
 
For clinical governance to be successful, health organisations must demonstrate: 
following features: 
a) An open and participative culture 
b) A commitment to quality that is shared by staff and managers 
c) A comprehensive programme of quality improvement systems.40 
 
With this in mind a quality improvement cycle took place between October 2012 and 
November 2013 following the usual steps listed below and shown in Figure 1 and also 
Appendix 1: 
 Involving the practice/quality assurance team  
 Agree criteria and set target standards 
 Collecting and analyzing the relevant data 
 Evaluating the information and planning change 
 Implementing change  
 Re audit  
 
Figure 1: Quality improvement cycle 
 
Set target 
standards 
Collect and 
analyse date 
Evaluate 
results and 
plan change 
Implement 
change 
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Setting 
The QIC took place at Cloetesville Community Day Centre (CDC) in the Stellenbosch area 
of the Cape Winelands. Stellenbosch is a town in the Western Cape Province of South 
Africa. The Stellenbosch sub district as a whole has a population of approximately 
156,000 according to Census data 201141 although the local municipality estimates the 
current population to be 180,000 because many informal settlements were uncounted. 
The Cloetesville area comprises of about 25,000 people. The Stellenbosch sub-district 
has 10 community health centres with 6 mobile clinics and has Stellenbosch Hospital as 
its district hospital. On average the Cloetesville CDC sees 3,300 patients per month, but 
it is currently unclear how many of the headcount is for chronic disease and 
hypertension.   
Cloetesville and its surrounding areas is a low to middle income area with a majority of 
Afrikaans speaking coloured people. The Cloetesville CDC has one permanent medical 
doctor since late 2012. Before 2012 there was no permanent medical doctor, but only 
visiting doctors who did sessions. It is clear from my time at this facility that before 
2013 the chronic disease programme was not well done and the performance was 
substandard. The facility has an operational manager, 5 clinical nurse practitioners, 1 
staff nurse, 1 assistant nurse and 3 clerks in total. It has a small pharmacy department 
within the facility. The facility also has access to a physiotherapist, occupational 
therapist, and dietician once a month as well as community based services. There is no 
health promoter currently in the facility. The Cloetesville CDC has a chronic disease 
champion or responsible person in charge that is responsible for the chronic care 
programme, but most of the nursing staff sees patients with chronic diseases, including 
hypertension, on a day to day basis. Currently stable or controlled hypertensive patients 
see the doctor annually and nursing staff twice a year. 
Study population and sample size 
The study population included patients with a diagnosis of hypertension who were 18 
years or older and under the care of the Cloetesville CDC for a period of 6 months or 
more. Patients younger than 18 years, pregnant, less than 6 months on treatment or less 
than 6 months at the CDC were excluded.  
The sample size needed for this study was calculated with the assistance of the Centre 
for Statistical Consultation. The required sample size was calculated according to a 
power calculation where the same sample of patients was compared before and after 
the change to clinical practice. A sample size of 200 patients was required to detect a 
10% improvement in control of blood pressure (% of patients with systolic blood 
pressure <140) with a power of more than 90% and with a p value of 0.05. The 
calculation was based on blood pressure readings obtained during another study on a 
similar group of patients attending local health centres.  
This study randomly selected 200 patient records of hypertensive patients at the onset 
of the study and then audited those specific patient records at baseline and after the 
implemented interventions 1-year later. The staff was not aware of which patients were 
included in the study. Six patients died during the study year before the second audit 
2014.  Therefore the sample size with paired data was reduced to 194. The sample 
however appeared to be adequately powered to detect significant differences in the re-
audit. 
Stellenbosch University  https://scholar.sun.ac.za
  10 
 
Involving the practice team 
Quality improvement is usually a team effort as ownership of the process by the people 
involved is more likely to lead to change in practice than when it is perceived as 
criticism by an outside researcher or individual. The researcher met with all staff 
members involved with chronic care at Cloetesville CDC. We formed an audit team that 
consisted of medical practitioners (the researcher and another doctor who works at 
clinic), the operational manager, nursing staff and pharmacist. The researcher practises 
once a week in the facility and has become involved in the clinical governance and 
quality assurance activities. 
Development of target standards (criteria and performance levels) 
The audit team formulated and agreed upon the criteria and performance levels to 
develop target standards. The team referred to the evidence based guidelines on 
hypertension developed by the Southern African Hypertension Society.15 The team also 
looked at the integrated audit of chronic disease management (IACDM) criteria42 (see 
Appendix 2 and 3) and audits performed in similar settings30 and their own experience, 
when setting criteria and performance levels. The criteria were divided into three 
groups: 
 Structural criteria e.g. infrastructure, equipment, medication, human resources 
 Process criteria e.g. activities conducted during patient visits 
 Patient outcome criteria e.g. control of BP 
 
The structural criteria 
The audit team decided on the following structural criteria: 
 There is a functional and calibrated sphygmomanometer (BP machine) in each of 
the consultation and observation rooms.  
 There is at least one small, medium and obese blood pressure cuff size available 
for the facility.  
 There is one functional weighing scale  
 There is one functional height scale  
 There are evidence based hypertension guidelines in the facility 
 There are investigation request forms in each consultation room 
 There are specimen tubes for blood tests in each consultation and procedure 
room. 
 There is a functional ECG machine at the facility 
 There are specimen bottles for urine to screen for proteinuria in the facility 
 There is a literate and illiterate Snellen/visual aquity chart in the facility 
 All doctors’ rooms have an ophthalmoscope and there are two additional mobile 
sets in the facility. 
 All pharmaceutical agents for BP control (two different types of diuretics agents, 
beta blocker, angiotensin converting enzyme inhibitor (ACE-I), calcium channel 
blocker and alpha blocker) available in the facility. 
 Eye drops for dilatation of pupils available in the facility. 
 BMI wheels/ charts in all observation rooms and consultation rooms. 
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 Glucometer with testing strips in all the observation rooms. 
 
Process criteria 
The selected process criteria are listed in Table 2. This study did not assess eye 
screening for hypertension as it was not seen as a key indicator of quality and the audit 
team were not convinced that this would have a major impact on the quality of care for 
hypertension for this facility. 
This audit also looked for evidence of any ECG performed and not just for the last year. 
The team were aware of the poor adherence to the guidelines, which requires annual 
ECGs or clinical assessment of left ventricular hypertrophy (LVH). However it was 
decided by the audit team to only perform an ECG in patients who were symptomatic 
since there was uncertainty as to whether it would make a major difference to overall 
care in a staff and time limited setting. The compromise was to aim for at least one 
baseline ECG for each hypertensive patient in the file. The doctors were also encouraged 
to assess for LVH clinically.  
Lifestyle counselling for this study included any counselling by a health care worker in 
the facility on smoking cessation, dietary advice, alcohol use, physical activity, 
medication adherence or understanding hypertension. 
Outcomes criteria 
The outcome criteria are listed in Table 3. The average BP was recorded and was 
defined as BP< 140/90 or < 130/80 in those with DM, CVD, CRF. The average of the BP 
reading/s over a one year period was taken. Significant proteinuria for this study was 
defined as >1+ protein in the urine. 
Target organ damage (TOD) noted in patient files was recorded from the problem list, 
previous notes and referral letters. This included IHD, CRF, CVA, LVH, retinopathy, and 
admissions for malignant hypertension. 
Resistant BP for this study was defined as a hypertensive patient being on 4 or more 
antihypertensive drugs on maximum or full dosage and with the BP still uncontrolled.  
Data collection 
Administrative staff was instructed to randomly select 200 hypertensive patient files off 
the shelves for inclusion in the audit. This was necessary as there was no disease 
register to identify the patients, although patient files were colour coded for 
hypertension. 
The first data collection occurred in November 2013. Data from the previous year in the 
medical records were captured onto an electronic data collection sheet in Microsoft 
Excel designed by the researcher. Patients who moved, were not seen for more than one 
year or transferred out were not considered and these files were discarded and new 
patient records were selected. 
Structural criteria were assessed by inspection and reported as present or not present. 
Performance levels required total compliance with the criteria. The data for the 
structural criteria was obtained by two individuals using a checklist; one was the 
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researcher from the practice team and the other a doctor working at Stellenbosch 
hospital and therefore not involved in the CDC.  
Data analysis  
Descriptive statistics were used to report on the results at baseline and after 1-year 
using frequencies, percentages and 95% confidence intervals. Binary variables were 
summarized in frequency tables. McNemar's chi-squared test was used to compare 
paired data and statistical significance was set at p<0.05. Stata, release 13 (StataCorp 
2007) was used for data analysis.  
 
Evaluating the information and planning change 
The results of the audit were presented to the audit team for discussion and compared 
to the target standards. We then discussed, interpreted and decided on necessary 
changes to clinical practice.  
Implementing change 
The agreed changes to clinical practice and educational activities were implemented by 
the audit team over the study period with the help of the staff involved in chronic care. 
The re-audit  
Data collection, data analysis and interpretation were repeated 12 months after the 
initial audit on the same 200 patient records. This period allowed time for the changes 
to be implemented.  The results from the two audits were compared to determine if 
there was a statistically significant improvement (p<0.05) in each criteria and how 
many of the target standards were met before and after the intervention. 
Ethical considerations 
The dignity, human rights, safety and wellbeing of participants were assured. An 
approval to conduct the present study was obtained from the Health Research Ethics 
Committee of Stellenbosch University (S13/04/77) and Director of the Cape Wine lands 
district.  This was a retrospective clinical audit therefore a “waiver of informed consent” 
was requested from the Stellenbosch Ethics Committee. The research aimed to improve 
patient outcomes and health in Cloetesville and its surrounding areas and was directly 
beneficial to the hypertensive patients attending the health centre. The risk of this study 
was negligible since it sought to improve adherence to current best practice and policy 
as defined in the accepted national guidelines for hypertension care in primary care. 
This study therefore had a favourable risk-benefit ratio. The information was collected 
by only using file numbers on the data schedule to protect patient confidentiality. The 
final results reflected general trends in hypertension care and did not refer to any 
particular individual. 
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Results 
Study population 
Out of the baseline sample of 200 participants, 119(59.0%) were female and 81(41.0%) 
were male with an average age of 58 years. Six patients died during the study period 
and could not be followed up, giving a death rate of 3.0%. It is important to note that 95 
(48.0%) of the study population had co-morbid diabetes mellitus. 
Comparing actual performance to the target standards 
The results of the baseline and second audit for the structural criteria are given in Table 
1. Out of the 14 criteria all met the target at baseline and in the second audit, which 
implies that the health centre had sufficient resources to provide the desired quality of 
care. 
Table 1: Results of the audit of structural criteria 
Criteria Target 
performance 
Audit  
2012- 
2013 
Audit 
2013-
2014 
Health centre has 
a weight scale 
Yes  Yes  Yes  
Health centre has 
a tape measure 
Yes Yes Yes  
Health centre has 
a height 
measurement 
Yes Yes Yes  
BP monitors with 
three cuff sizes 
Yes Yes Yes  
Health centre has 
equipment for 
urinalysis 
Yes  Yes Yes  
Health centre has 
snellen chart 
Yes Yes Yes  
Ophthalmoscope 
in each doctor’s 
room 
Yes Yes Yes  
Each consultation 
room has BMI 
wheels/charts 
Yes  Yes  Yes  
Glucometer 
sticks 
Yes  Yes  Yes  
Eye drops for 
dilatation of 
fundi 
Yes  Yes  Yes  
Anti-
hypertensive 
Yes  Yes  Yes  
Stellenbosch University  https://scholar.sun.ac.za
  14 
 
drugs in health 
centre 
Health centre has 
hypertension 
guidelines 
Yes Yes Yes  
ECG machine in 
health centre 
Yes  Yes  Yes  
*Equipment for 
taking blood 
samples in health 
centre 
Yes  Yes  Yes  
*Includes laboratory forms, blood tubes, transport etc.  
Table 2 shows the results of the process criteria. Although only 3 out of the 12 target 
standards were met on follow up, there was a significant improvement in performance 
in 9 out of 12 criteria. There was also a significant decrease in performance in 2 out of 
12 as the percentage of patients with observation of weight and blood pressure 
decreased.  
Table 2: Results of the audit of the process criteria  
Criteria Target 
% 
Audit  
2012- 
2013 
N=200 
n (%) 
Audit 
2013-
2014 
N=196 
n (%) 
Change in % 
(95% CI)  
P value 
 
Check sheet in 
each file 
95 177 
(90.3) 
193 
(98.5) 
8.1 (3.8;12.5) <0.001 
Check sheet 
updated 
annually 
90 131 
(68.8) 
171 
(87.2) 
20.4 
(14.3;26.6) 
<0.001 
Weight during 
year 
95 192 
(97.9) 
176 
(89.8) 
-8.0 (-12.5;-3.8) <0.001 
BMI recorded 
annually  
80 120 
(61.2) 
157 
(80.1) 
18.0 
(12.9;24.9) 
<0.001 
BP check at 
least twice a 
year 
100 162 
(82.6) 
154 
(78.6) 
-4.0 (-7.4;-0.8) 0.007 
Urinalysis at 
least once a 
year 
100 160 
(81.6) 
181 
(92.3) 
10.0 (5.9;15.6) <0.001 
Creatinine 
annually 
95 111 
(56.6) 
180 
(91.8) 
35.2 
(28.0;42.4) 
<0.001 
Total 
cholesterol 
annually 
90 106 
(54) 
178 
(91) 
36.7 
(29.5;44.0) 
<0.001 
Counselling 
on lifestyle 
chances 
90 87 
(44.3) 
196 
(86.2) 
41.8 
(34.3;49.4) 
<0.001 
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ECG at least 
once recorded 
in file 
30 26 
(13.3) 
31 
(15.8) 
2.5 (-0.2;5.3) 0.063 
Dietician 
referral at 
least once in 
file 
30 14 
(7.1) 
20.0 
(10.2) 
3.0 (0.1;6.0) 0.031 
Random 
glucose done 
annually 
90 138 
(70.4) 
175 
(89.2) 
18.8 
(12.7;25.1) 
<0.001 
 
Table 3 shows the results for the outcome criteria. Only 5 out of the 10 outcomes 
achieved the target standard at baseline and only 4 out of 10 on follow up. Although not 
significantly different the % of patients identified with TOD increased above the desired 
performance level at follow up, leading to the fall in number of criteria achieving the 
target. This could of course represent a better process of care, with better recognition of 
TOD, rather than an actual increase in the prevalence of TOD. 
The percentage of patients controlled increased from 58% to 61%, which was 
statistically significant, although only a modest improvement. Two other outcomes 
improved significantly, namely the percentage of patients with a controlled total 
cholesterol and creatinine, whereas the percentage of patients with obesity significantly 
increased. 
Table 3: Results of the audit of outcome criteria 
Criteria Target 
% 
Audit 
2012–  
2013 
N=200 
n (%) 
Audit 
2013-
2014 
N=196
n (%) 
Change in % 
(95% CI)  
P 
values  
Average BP< 140/90 
or < 130/80mmHg in 
DM,CVD,CRF 
90 113 
(57.6) 
119 
(60.7) 
3.0 (0.1;6.0) 0.03 
Proven target organ 
damage/hypertension 
related complications 
in folder 
<15 29 
(14.7) 
42 
(21.4) 
6.6 (-2.0;15.3) 0.11 
Cholesterol <5 
mmol/L 
80 41 
(20.9) 
90 
(45.9) 
25 (18.4;31.6) <0.001 
Creatinine 
<120mmol/L 
90 100 
(51.0)    
167 
(85.2) 
34.0 
(27.0;41.3) 
<0.001 
Resistant BP <20 8.0 
(4.0) 
14  
(7.1) 
3 (-2.1;8.2) 0.20 
BMI <30kg/m2 <40 72 
(60.0) 
62 
(51.6) 
-8.3(-14.1;-2.6) 0.002 
Proteinuria  <10 29 
(14.8) 
19 
(9.7) 
-5.1(-12.5;2.3) 0.15 
Prevalence of <10 21 28 3.5(-2.9;9.9) 0.24 
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hypertensive heart 
disease 
(10.5) (14.0) 
Prevalence of chronic 
kidney disease 
<5 9.0 
(4.5) 
8.0 
(4.0) 
-0.5(-4.8;3.8) 0.79 
Prevalence of strokes <5 8.0 
(4.0) 
10 
(5.0) 
1(-3.7;5.7) 0.63 
Note that the BMI<30 was calculated with a total out of 120 since only 120 BMI measurements were done. 
Changes to clinical practice 
Interventions included patient flow and procedural aspects of care and educational 
presentations, which focused on the problem areas identified by the first audit and the 
audit team’s experience.  
In terms of patient flow the team looked at making changes to the appointment system 
as it was not effective. Appointments with the doctor were rather controlled on a 
computer booking programme and dates for the pharmacy were given on the patient’s 
booking card. The technique of how BPs measurements was addressed in the audit 
since as mentioned before that accurate BP measurement is important since as noted 
earlier BP measurements when high has a significant risk for cardiovascular disease.  
Training activities focused on the procedure for measuring blood pressure using a 
standardised protocol as stipulated in Appendix 4. 
Educational presentations focused on the evidence based hypertension guidelines and 
promoting standards of care. Teaching was done by the researcher by means of small 
group sessions and occurred twice during the year. 
The researcher reinforced use of the chronic disease management (CDM) flow sheet 
that had previously been developed by the province as shown in Appendix 5. The flow 
sheet records the process of care on one sheet of paper and therefore improves 
continuity of information and prompts the healthcare worker to perform any missing 
activities, such as routine screening tests. In the past there were a flow sheet for every 
chronic disease which meant more paper work and staff members was less likely to use 
the tool. The new flow sheet was modified to have one sheet for all chronic diseases, 
which was well received. There was a group discussion with the staff on recording what 
gets done, note keeping and the importance of documenting chronic disease 
management for quality care.  
The researcher also had a small group discussion with the staff regarding counselling on 
lifestyle modification looking at diet, exercise, smoking and alcohol abuse. The 
documentation of counselling was also reinforced.  
Although the structural aspects where in place the instruments such as the BP machines 
and weight scales were calibrated and requisition forms kept on record as proof. 
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Discussion 
Summary of key findings 
The structural criteria met all the target standards and this is mostly likely due to the 
IACDM audit having been conducted annually over the last few years. The health centre 
therefore had all the essential resources to offer a high quality of care. Overall the 
process of care improved in terms of better recording of information and increased 
monitoring of patients for complications (urinalysis, creatinine, and total cholesterol), 
risk factors (BMI) and co-morbidity (diabetes). It was encouraging seeing an increase in 
patient education and counselling activities. The percentage of patients achieving a 
controlled BP was 61% and this is just slightly higher than the results of the IACDM for 
the whole province at 56%.42  
The slight improvement in blood pressure control in this study is supported by other 
studies where improving the technical quality of care was an effective strategy for 
improving blood pressure control and was achieved by relatively simple interventions 
within quality improvement cycles.43 Key changes to clinical practice that appeared to 
be responsible for these improvements were improvement in the patient flow in the 
facility, teaching on hypertension guidelines and the technique of BP measurements.  
Although the recording of weight decreased, the calculation of BMI, which is a more 
accurate measurement of overweight and obesity, increased. The recording of ECGs was 
not given much priority or attention and there was little attempt made to clinically 
identify LVH. Although referrals to the dietician increased slightly the dietician was 
more focused on people with diabetes and was also absent for a large part of the year. 
The measurement of creatinine and cholesterol improved together as blood was taken 
for both at the same time and the need to do this was reinforced in teaching. There may 
have been some reluctance to repeat these tests annually when they had previously 
been normal due to the cost and questions regarding the value of repeated 
measurements.  
This facility also started a central dispensing units (CDU)/ pre pack system for chronic 
diseases. This CDU were introduced in April 2014 of the study year and is currently 
working well.  Another change in the system of care for the facility was the switching to 
the electronic scripts (JAC online system) for the prescription of patients, which started 
in August 2014 of the study year. All these changes to the system were well received 
and should have led to better patient care, less time spent in the clinics and more time 
for medical practitioners to consult patients. It is however the researchers view that 
these changes to practice did not have a major impact on the results of this study and 
quality of care for hypertension since they were introduced very late in the study year. 
However it is expected to enhance quality of care in the future.  
The audit also found that 48% of hypertensive patients had co-morbid DM, which is 
higher than the 18% reported nationally in primary care. 27 This higher figure may be 
due to better recognition of diabetes in our setting, but also to higher prevalence rates 
in this peri-urban community.44 
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Discussion of the findings in relation to literature and policy  
The benefit of having the flow sheet is that it is the first thing you see when opening the 
file and makes you actively assess the patient’s progress.45, 46 Counselling on diet, 
exercise, alcohol abuse and smoking was better documented when the flow sheets was 
used. In general there was better recording of and access to information when the flow 
sheet was used. 
This audit illustrates the need for better lifestyle and behaviour change counselling 
when looking at the high BMI, DM status and number of people with high total 
cholesterol levels. Although patient education and counselling improved there is 
uncertainty with regards to the quality and type of counselling on behaviour change 
that was offered. The Seventh report of the Joint National Committee on prevention, 
detection, evaluation and treatment of high blood pressure (JNC7) suggests that health 
care providers give insufficient attention to health education. Recent local studies have 
shown that primary care providers are poorly trained in counselling, experience many 
barriers and have limited knowledge of lifestyle modification.47 Major reviews of the 
research on lifestyle interventions show that brief behaviour change counselling by 
health care providers can be effective in changing non communicable diseases (NCD) 
risk behaviours and improving self-management among patients with existing chronic 
conditions.48,  49 The Chronic Disease Initiative for Africa has recommended an approach 
that provides structured and comprehensive group education, that is supported by 
patient education materials and ad hoc brief behaviour change counselling from 
primary care providers. Despite the improved frequency of counselling in this study the 
staff should look at assessing the quality of such counselling and the need for a more 
comprehensive approach.  
The South African government’s recent national strategic plan to control the NCD 
epidemic (Department of National Health, 2012) places a strong emphasis on the need 
to improve the detection, early intervention and management of NCD lifestyle related 
risk factors, particularly at the level of primary health care. This includes a focus on 
strengthening the capacity of health service staff to provide brief counselling on the 
main lifestyle risk factors for NCDs.  
The reasons for failing to improve BP control should be further explored and addressed.  
The overall control of BP, which was still only 61% in this study, does not necessarily 
only reflect poor health care, but also patient factors such as non-adherence, low 
education, socio economic factors and possibly secondary causes for hypertension. It is 
however important to look at the interaction of patients with the facility and health 
workers. Other reasons for non-adherence to consider are side effects that discourage 
patients from taking medication; poor understanding of the condition or medication so 
that, for example, patients only take medication when they experience symptoms 
attributed to hypertension; lack of support by family members; or difficulty in obtaining 
antihypertensive medication.50 Many of these factors are modifiable by healthcare that 
is more patient-centred with adequate education and counselling. These issues, which 
are more difficult to measure than technical tasks, should maybe be assessed more in 
future audits. 
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Cardiovascular risk factors, such as blood cholesterol, were still uncontrolled with less 
than 50% of the study group achieving the target. This is on the background of many 
patients being on statins or lipid lowering drugs. This indicates a further need for 
patient education and counselling to enhance behaviour change and adherence.  
Patients with resistant hypertension should be referred to a secondary level facility 
according to the SA hypertension guidelines. However this is not always possible in this 
setting with scare resources and over loaded specialist services. Many of these patients 
though actually have problems with understanding, motivation, adherence, side effects 
and other factors which do not necessarily need a referral, but more patient-centred 
care, education and counselling. 
Some of the criteria measured were similar in both audits such as weight done and 
documentation of counselling. There was a clear improvement in annual bloods done 
with Creatinine and total cholesterol improving from 70% and 60% to 92% and 91% 
respectively. There was some improvement in the total cholesterol<5 with unchanged 
results for Creatinine. There was an improvement in BMI measured and documented 
but it’s important to note that the IACDM looked at BMI<25 with this study looking at 
measurements <30 kg/m2.  
The random glucose done for the 2012-2013 IACDM was 40% with this study showing 
results of 90%, a significant improvement since as mentioned previously this has 
important health implications. Co-morbid DM was not measured with the IACDM. The 
IACDM had a BP control of 60% which is unchanged for this study. 
Target organ damage, urinalysis and valuable CDM clinic record flow sheet was not 
assessed in the IACDM. This could be considered and possibly added for the IACDM 
audit. 
Limitations 
It is important to note that although lifestyle changes such as counselling on behaviour 
change might have been done if it is not recorded then this will not reflect in the audit. 
Also the assessment of the amount of target organ damage and hospital admissions for 
hypertension related complications may potentially not be as accurate they might not 
have been recorded. 
A significant change that occurred at the time of the start of the initial audit in 2013 was 
the transfer out of patients to other facilities who were not from the drainage area of 
Cloetesville. Cloetesville CDC used to drain a larger area and was responsible for several 
other programmes in this sub district. The transfer out of patient to clinics nearer to 
them would have impacted on the operations for this facility. The researcher is of the 
opinion that this did not significantly influence the findings of this study. These patients 
might possibly even have better hypertension care if they attend a medical facility 
closer to home since it would be easier to attend clinic and likely lead to better 
continuity of care.  
Several of the patient outcomes were also dependent on the process of care and were 
difficult to measure if few patients had the test or may appear to have deteriorated 
when improved process of care led to better recognition of the problem. 
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Recommendations 
This QIC gave us a real sense of the quality of care for this health centre. There were 
some aspects addressed in this cycle that could be further explored and some areas that 
was not included in this cycle that should be looked at in future cycles.  
“Quality is never an accident; it is always the result of high intention, sincere effort, 
intelligent direction and skilful execution; it represents the wise choice of many 
alternatives.”–William A Foster.51 Importantly, this audit forms part of a continuous 
process which necessitates the commitment and buy-in of key stakeholders: the 
public/patients, the clinical personnel and the health system management. This study 
recommends patient representation in the audit team with future cycles.  
Primary healthcare (PHC) is the foundation of SA healthcare with hypertension being 
one of the most common non communicable diseases (NCDs) which is mostly managed 
by nurses. Thus future training and guidelines should adequately address hypertension 
and the complexity inherent in this consultations.13 This includes being more patient-
centred with skills in brief behaviour change counselling and assessment of overall CVD 
risk.52 Greater involvement of doctors in managing more complicated patients with 
multi morbidity should also be considered.  
Although counselling for lifestyle changes improved there remains a further need for 
emphasising the non-pharmacological treatment modalities and exploration of the type 
and quality of counselling. The approach to patient education and counselling needs to 
be revisited. Such interventions involve measures at a macro level which create 
enabling environments for healthy lifestyles through policy and legislation, and 
interventions at an individual level which promote behaviour change.  It is here, that 
health care providers have a vital role to play in encouraging and supporting their 
patients or clients to make and maintain healthier lifestyle choices.53This also requires a 
multidisciplinary approach with health promotion programmes, group education and 
adherence support programmes.  
Better communication and co-ordination of care is needed between the health centre 
and the referral hospitals to ensure that investigations and management plans are 
shared and resources are not wasted through duplication. This could possibly be 
assessed with future cycles. 
The concept of measuring and responding to the absolute CVD risk is another important 
aspect not fully evaluated in this study.  
This assessment could lead to primary and secondary prevention of CVD, which in our 
setting would include a statin and aspirin. More emphasise and teaching on total CVD 
risk assessment and management should be considered with future cycles. A non-
laboratory based CVD risk score for use in SA has been developed.54  
This study did not assess the prescription charts, drug book and drug choices. An 
important consideration and possible outcome to measure in future QIC could be 
assessing the amount of side effects to treatment. The researcher also picked up many 
improper and inappropriate prescriptions.  
As discussed above future cycles should attempt to measure the quality of patient 
education and counselling and the capability of staff to deliver this. 
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Urine testing for proteinuria was done in most hypertension patients at the clinic but 
this audit gives no information on the clinical response to proteinuria. Angiotensin-
converting enzyme (ACE) inhibitors and angiotensin-II receptor antagonists 
preferentially lower intra-glomerular pressure and reduce proteinuria. Ample evidence 
shows that these agents are more effective than other anti-hypertensive drugs in 
preventing the progression of kidney disease.55 The same argument holds true for 
abnormal blood results, such as high cholesterol levels. Investigations are only useful if 
they lead to changes in the management plans that benefit patients. This concept has 
been called clinical inertia where a health worker acknowledges an abnormal result or 
uncontrolled BP, but fails to make changes that would lead to improvement of care. 
Clinical inertia has been shown to be a major contributor to poor BP control.56 Clinical 
inertia should be measured and addressed in future cycles.  
Conclusion 
An audit team created target standards for structural, process and outcome criteria 
related to the quality of care for hypertension. A baseline audit revealed that the health 
centre had the essential resources needed to provide quality care. Despite this only one 
of the twelve process target standards were met at baseline and this increased to three 
criteria on follow up. Blood pressure control rose from 58% of patients at baseline to 
61% at follow up. The audit team made changes to clinical practice that included 
improvements to the appointment system, more standardised BP measurement and 
teaching staff about the latest guidelines. Future audits should focus more on the quality 
of patient education and counselling, co-ordination of care with the referral hospitals, 
use of CVD risk scores, degree of clinical inertia, and rational prescribing. 
It is recommended that the quality improvement process should continue with new 
interventions, be expanded to other health centres in this sub district and beyond and to 
other chronic conditions.  
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Appendices 
Appendix 1: The Quality Improvement Cycle  
 
Involve the
practice team
Choose topic
Agree criteria
set target standards
Observe practice
collect data
Evaluate information
performance versus targets
Plan care
implement change
Medical Audit = Quality Improvement
Copy of PowerPoint Slide used in Teaching Intervention: the Quality Improvement Cycle 
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Appendix 2: Example of the IACDM tool for Hypertension  
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Appendix 3: Example of structural aspects in the IACDM 
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Appendix 4: Blood Pressure measuring technique 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Blood pressure measurement by standard mercury sphygmomanometer 
or semiautomatic device 
 
• Use a properly maintained, calibrated, and validated device 
• Measure sitting blood pressure routinely: standing blood pressure should be recorded 
at least at the initial estimation in elderly or diabetic patients 
• Remove tight clothing, support arm at heart level, ensure arm relaxed and avoid talking 
during the measurement procedure 
• Use cuff of appropriate size  
• Lower mercury column slowly (2 mm per second) 
• Read blood pressure to the nearest 2 mm Hg 
• Measure diastolic blood pressure as disappearance of sounds (phase V) 
• Take the mean of at least two readings, more recordings are needed if marked 
differences between initial measurements are found 
• Do not treat on the basis of an isolated reading 
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Appendix 5: Example of Hypertension Flow sheet 
 
  Patient Name 
 
Folder number 
 
 
 
 
 Id number/Date of 
birth 
 HEIGHT: 
 PREVENTION = at least once/year 
 DATE  
Weight =  
DATE  
BMI =  
DATE  
BP = 
DATE  
HGT =  
 DATE 
HCT done = Y/N 
DATE 
PAP smear {as 
indicated} Y/N 
 
 
 
  DIABETES      
Date diagnosed: 
HYPERTENSION 
Date diagnosed: 
DATE DATE DATE DATE DATE DATE 
EV
ER
Y
 C
LI
N
IC
 V
IS
IT
 (
EC
V
) 
O
B
S 
R
O
O
M
 
COUNSELLING       
Diet       
Exercise       
Smoke & ETOH       
Correct medication use       
Aspirin        
Simvastatin        
OBSERVATIONS       
Blood pressure       
Urine dipstick results       
Weight       
HGT        
A
N
N
U
A
L 
C
LI
N
IC
 V
IS
IT
 (
A
C
V
) 
C
N
P
/P
N
 
BMI (<25)  
Waist circumference (M<102cm; W<88cm) 
      
Snellen eye test       
 ECG if indicated       
 HGT       
Foot screening 
(Nurse) 
       
Dr Fundoscopy        
C
N
P
/P
N
 
 C
N
P
 
LAB BLOOD TESTS       
Cholesterol (Baseline)       
Creatinine       
HbA1C        
Framingham Cardiac Risk assessment       
Unstable/stable       
  EPILEPTIC PATIENTS 
Date diagnosed: 
      
EC
V
 
C
N
P
/P
N
 
Type of seizure       
COUNSELLING       
Lifestyle changes       
ETOH use/abuse       
Correct medication use       
Medication side effects       
SEIZURE INFORMATION       
Number of seizure last month       
Intervention if seizures recorded (Y/N/X)       
Number of emergency visits for epilepsy       
 
 BLOODS: 
………………………………..(Drug) level if 
uncontrolled) 
      
A
C
 
O
B
S 
OBSERVATIONS       
HIV Test       
CDM CLINIC RECORD 
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